Skip to Main Content

Author Details

Tammy Piper
University of Edinburgh
2012
21
12
PMIDPaper TitleJournal TitlePublished Year
36859649Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.Breast Cancer Res Treat2023
35144966Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.Clin Cancer Res2022
35526835Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.J Mol Diagn2022
36527133Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.Breast Cancer Res2022
34312396Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.NPJ Breast Cancer2021
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
32881987Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.PLoS One2020
31017314Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.Histopathology2019
30143750An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.Mod Pathol2019
28525534Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.Ann Oncol2017
28190252The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.Breast Cancer Res Treat2017
26717057Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.Arch Pathol Lab Med2016
28721378Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.NPJ Breast Cancer2016
27499914Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.J Pathol Clin Res2016
25698062An international study to increase concordance in Ki67 scoring.Mod Pathol2015
25071141Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.J Clin Oncol2014
25314051Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.Br J Cancer2014
23535839Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer.Breast Cancer Res Treat2013
24091623Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.Br J Cancer2013
24203987An international Ki67 reproducibility study.J Natl Cancer Inst2013
23045591Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study.J Clin Oncol2012
  • 1 - 21 of 21

Recommended Authors

Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 31
Leen Slaets
50148Janssen Pharmaceutica NV
Career Start Year 2014
Number of shared co-authors 27
Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 1
Konstantinos Tryfonidis
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 29
Theodora Goulioti
Career Start Year 2009
Number of shared co-authors 25
Melanie Spears
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 13
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 4
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 3
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 6
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 2
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 4
Sara M Tolaney
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 6
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 4
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 8
Alison F Munro
Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital
Career Start Year 2004
Number of shared co-authors 14
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 3
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 6
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 6
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 15
Matthew P Goetz
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 10
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 4
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 6
Giuseppe Curigliano
University of Milan
Career Start Year 1996
Number of shared co-authors 11
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 3
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 6
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 7
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 7
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 20

Collaborators

John M S Bartlett
University of Edinburgh
Co-authored papers 21
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 9
Christos Markopoulos
National and Kapodistrian University of Athens
Co-authored papers 7
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 7
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 7
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 7
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 7
Samuel Leung
University of British Columbia
Co-authored papers 5
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 5
Dirk G Kieback
Helios Medical Centre
Co-authored papers 4
Elizabeth Mallon
Queen Elizabeth University Hospital
Co-authored papers 4
Elizabeth N Kornaga
Tom Baker Cancer Centre
Co-authored papers 3
Cassandra L Brookes
Leicester Clinical Trials Unit, University of Leicester
Co-authored papers 3
Cheryl Crozier
Ontario Institute for Cancer Research
Co-authored papers 3
Charles Kent Osborne
Co-authored papers 3
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 3
Dennis C Sgroi
Co-authored papers 2
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 2
Carrie A Cunningham
Massachusetts General Hospital
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Peggy L Porter
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Karen J Taylor
University of Edinburgh
Co-authored papers 2
Mei-Yin C Polley
Co-authored papers 2
David L Rimm
Yale University School of Medicine
Co-authored papers 2
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 2
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers 2
Kim Benstead
Gloucestershire Hospitals NHS Foundation Trust
Co-authored papers 1
Barbro Linderholm
Sahlgrenska University Hospital
Co-authored papers 1
Danielle Van den Weyngaert
University of Antwerp
Co-authored papers 1
Sharon H Giordano
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2